Pharmacokinetic Study to Evaluate Double-Dose Levonorgestrel Emergency Contraception in Combination With Efavirenz-Based Antiretroviral Therapy or Rifampicin-Containing Anti-Tuberculosis Therapy
Clinical trial NCT03819114 · COMPLETED
Trial details
- NCT number
- NCT03819114
- Sponsor
- Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-06
- Primary completion
- 2020-11-02
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.